.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Healthtrust
Farmers Insurance
AstraZeneca
QuintilesIMS
Queensland Health
Teva
Express Scripts
US Army
Cipla
Mallinckrodt

Generated: July 20, 2017

DrugPatentWatch Database Preview

CITANEST FORTE DENTAL Drug Profile

« Back to Dashboard

Which patents cover Citanest Forte Dental, and when can generic versions of Citanest Forte Dental launch?

Citanest Forte Dental is a drug marketed by Dentsply Pharm and is included in one NDA.

The generic ingredient in CITANEST FORTE DENTAL is epinephrine bitartrate; prilocaine hydrochloride. There are nineteen drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the epinephrine bitartrate; prilocaine hydrochloride profile page.

Summary for Tradename: CITANEST FORTE DENTAL

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Clinical Trials: see list540
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:CITANEST FORTE DENTAL at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Dentsply Pharm
CITANEST FORTE DENTAL
epinephrine bitartrate; prilocaine hydrochloride
INJECTABLE;INJECTION021383-001Approved Prior to Jan 1, 1982APRXYesYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Queensland Health
US Department of Justice
Fish and Richardson
Dow
Moodys
Colorcon
Merck
McKinsey
Medtronic
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot